Clindamycin-resistant group B Streptococcus and failure of intrapartum prophylaxis to prevent early-onset disease.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 20056242.
- Also identified by DOI 10.1016/j.jpeds.2009.10.048 and PMC identifier 3153078.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Guidelines recommend intrapartum antibiotic prophylaxis (IAP) for parturient women who have a screen positive for group B Streptococcus (GBS). Clindamycin should be used for IAP only if the maternal GBS isolate is susceptible. We report a case of clindamycin-resistant GBS disease in a newborn infant whose mother received clindamycin IAP, and we review clindamycin susceptibility testing.
Medical subject headings
- Antibiotic Prophylaxis
- Clindamycin
- Infectious Disease Transmission, Vertical
- Streptococcal Infections
- Streptococcus agalactiae